StockData
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31

Lumexa Imaging Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.72−0.06 (-0.56%)

Close on Oct 19, 2026

Market cap
$1.03B
P/E (TTM)
–
Dividend yield
–

About Lumexa Imaging

Services-Medical Laboratories, SIC 8071

Lumexa Imaging Holdings, Inc. provides diagnostic imaging services in the United States. The company offers a range of advanced and routine medical imaging modalities, including magnetic resonance imaging, computed tomography, positron emission tomography, x-rays, ultrasound, and mammography. It also operates Connexia, an internal teleradiology platform that transmits radiographic images to remote, subspecialized radiologists for clinical interpretation. Lumexa Imaging delivers these diagnostic procedures to patients who require screening and diagnostic evaluations, serving individuals referred by affiliated healthcare providers, independent medical practices, and health system partners.

The company is headquartered in Raleigh, North Carolina. Lumexa Imaging operates 188 outpatient imaging centers located across 13 U.S. states, including eight joint venture partnerships with regional health systems. Its clinical network is supported by approximately 350 employed radiologists alongside contracts with over 890 radiologists in independent medical groups, handling patient referrals across tens of thousands of physician practices nationwide.

Summary of the business section of Lumexa Imaging's latest annual report, written by StockData.

Company profile

Company

Legal name
Lumexa Imaging Holdings, Inc.
Founded
2018
Headquarters
Raleigh, NC
Address
4200 Six Forks Road, Suite 1000 27609
Phone
(704) 334-7830
Industry
Services-Medical Laboratories
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
LMRI
Exchange
Nasdaq
IPO date
Dec 12, 2025
Shares outstanding
96M, Aug 12, 2026
Filer category
Non-accelerated filer<br>Emerging growth company
SEC CIK
2071288
CUSIP
550249106
ISIN
US5502491062
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Caitlin ZullaChief Executive Officer, Director129,728
James Edward Walker Jr.Principal Accounting Officer17,346
James Anthony MartinChief Financial Officer54,054
Russell StewartChief Medical Officer4,232
Julie SzekerChief Legal Officer & Corp Sec66,182
Bridget E. KarlinDirector19,358
Glenn A. EisenbergDirector19,358
Molly JosephDirector46,385
Henry Lee CooperDirector49,358
Robert Louis Mittl Jr.Director19,358
Brett BrodnaxDirector81,385
Matthew LungrenDirector19,358
Brian Thomas ReganDirector–

Corporate history

Events identified from SEC filings